Hermed links til abstracts på EHAs hjemmeside:
Daratumumab, a CD38 Monoclonal Antibody in Patients with Multiple Myeloma - Preliminary Efficacy and Pharmacokinetics Data from a Dose-Escalation Phase I/II Study
https://www.eventure-online.com/eventure/publicAbstractView.do?id=193081&congressId=5650
Reconstructing the Human Hematopoietic Niche: Opportunities for Studying Normal and Malignant Hematopoiesis
https://www.eventure-online.com/eventure/publicAbstractView.do?id=194581&congressId=5650
Towards Personalized Medicine Using a Novel Preclinical Model: Identifying Daratumumab as Effective Treatment for Multiple Myeloma
https://www.eventure-online.com/eventure/publicAbstractView.do?id=194208&congressId=5650
Daratumumab, a CD38 Monoclonal Antibody in Patients with Multiple Myeloma - Preliminary Efficacy and Pharmacokinetics Data from a Dose-Escalation Phase I/II Study
https://www.eventure-online.com/eventure/publicAbstractView.do?id=193081&congressId=5650
Reconstructing the Human Hematopoietic Niche: Opportunities for Studying Normal and Malignant Hematopoiesis
https://www.eventure-online.com/eventure/publicAbstractView.do?id=194581&congressId=5650
Towards Personalized Medicine Using a Novel Preclinical Model: Identifying Daratumumab as Effective Treatment for Multiple Myeloma
https://www.eventure-online.com/eventure/publicAbstractView.do?id=194208&congressId=5650
